VaxArray® Coronavirus SeroAssay Kits
Rapid quantification of CoV related antibodies in animals or humans
Coming Soon – The Coronavirus Serology Kit is designed to streamline pre-clinical and clinical studies for SARS-CoV2 vaccine candidates, and to aid in epidemiological seroprevalence studies for SARS-CoV2.
VaxArray Coronavirus SeroAssay Kits contain 64 microarrays and reagents needed to quantify CoV2 and related antibodies in animal or human samples. The test is a multiplexed immunoassay in which a panel of antigens is used to capture CoV antibodies for quantification. Results are based on fluorescence from an antibody-specific detection label conjugated with a proprietary fluorophore.
Assay features include:
- Specific and Multiplexed: Distinguishes anti-SARS-CoV-2 antibodies from other coronavirus antibodies.
- Off the Shelf: Streamlines testing and can be used with standardized reagents. Time to result is less than 2 hours.
- Fast and High Throughput: Potential for analyzing 100s samples/day.
- Automated Image and Data Processing: Reduces time spent processing data and maintains digital records with audit log traceability.